Go Pro

Dermata Therapeutics (DRMA) News Today

Dermata Therapeutics logo
$1.21 0.00 (0.00%)
As of 09/4/2026 04:00 PM Eastern

Dermata Therapeutics Latest News

Dermata Therapeutics, Inc. (NASDAQ:DRMA) Short Interest Update
DRMA Share News Today
Dermata Therapeutics, Inc. (DRMA) - Yahoo Finance
Dermata Therapeutics Faces Nasdaq Delisting Notice
Dermata Therapeutics receives notice of acceptance for Australian patent
Dermata Therapeutics files to sell 1.94M shares of common stock for holders
Dermata Therapeutics to prices 2M shares at $1.27 in private placement
Dermata Therapeutics receives FDA approval for Xyngari proprietary name

Dermata Therapeutics Media Mentions By Week

Dermata Therapeutics Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

DRMA
News Sentiment

0.00

0.76

Average
Consumer Staples
News Sentiment

Dermata Therapeutics News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

DRMA Articles
This Week

0

1

DRMA Articles
Average Week

Dermata Therapeutics Trends on MarketBeat

This week vs. last week
Page Views
1,424
+8%
Get Dermata Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for DRMA and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Dermata Therapeutics dated 8/17/2026.
From Our Partners